India Sulbactam Market to grow at a steady rate During the Forecast Period
Growing prevalence of
microbial infections is expected to drive the growth of India sulbactam market.
According to
TechSci Research report, “India
Sulbactam Market By Composition (Single, Combinational), By Source
(In-house v/s Contract Manufacturing Organizations), By Form (Intramuscular
injection, Intravenous injection, Powder Solution, Others), By Distribution
Channel (Online v/s Offline), By Application (Respiratory Infections, Skin
Infections, Urinary Infections, Others), By End User (Adult v/s Pediatric), By
Company, By Region, Forecast & Opportunities, FY2026”, the India sulbactam market is expected to grow at a steady
rate during the forecast period on account of the widespread use of the drug in
combination with ampicillin. Additionally, the medication
is effective against a broad spectrum of gram positive and gram negative
bacteria. Furthermore, sulbactam is effective against different infections
caused by A. baumannii
including meningitis, catheter-linked bacteremia, among others. Besides, sulbactam
is helpful in the treatment of respiratory infections, skin infections, urinary
infections, among others. However, side effects such as diarrhea, nausea,
vomiting, among others can restrict market growth through FY2026. Also, other
side effects observed due to consumption of sulbactam include hypersensitivity
reactions including anaphylaxis, acute blood nephritis, among others.
Sometimes, seizures are also observed due to overdose of the medication. These
factors further hinder the market growth during the forecast period.
Browse XX market data Tables and XX Figures spread
through XXX Pages and an in-depth TOC on" India Sulbactam Market"
https://www.techsciresearch.com/report/india-sulbactam-market/5145.html
The India
sulbactam market is segmented based on composition, source, form, distribution
channel, application, end user, company and region. Based on composition, the
market can be split into single and combinational. The combinational segment is
expected to dominate the market since it helps in preventing the antibiotic
activity of different antibiotics and also increases their antibacterial
spectrum. Based on distribution, the market can be split into online and
offline. The offline channel is expected to dominate the market owing to the
consumer preference for buying medicines from a pharmacy or drug store. The
online segment is also expected to register significant growth over the next
few years. This can be ascribed to the emergence of several online pharmacies
and doorstep drug delivery digital and e-commerce platforms in the country.
Fresenius
Kabi India Pvt. Ltd., M N Pharmaceuticals Pvt. Ltd., Morepen Laboratories Ltd.,
Unichem Laboratories Ltd., Hospira Healthcare India Pvt. Ltd., AdvaCare Pharma
LLP, Innovexia Lifesciences Private Limited, Osper Pharmaceuticals Pvt. Ltd.,
Torrent Laboratories Pvt. Ltd., Glenmark Pharmaceuticals Ltd. and others are some
of the leading players operating in India sulbactam market. Companies operating
in the market are using organic strategies such as product launches, mergers and
collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5145
Customers can also
request for 10% free customization on this report.
“India sulbactam market is
expected to witness growth during the forecast period on account of the growing
focus of the government in making the country self-sufficient with respect to
API manufacturing and drug development. Additionally, the extensive use of the
medication in combination with various antibiotics is further expected to fuel
the market growth through FY2026.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Sulbactam Market By
Composition (Single, Combinational), By Source (In-house v/s Contract Manufacturing
Organizations), By Form (Intramuscular injection, Intravenous injection, Powder
Solution, Others), By Distribution Channel (Online v/s Offline), By Application
(Respiratory Infections, Skin Infections, Urinary Infections, Others), By End
User (Adult v/s Pediatric), By Company, By Region, Forecast &
Opportunities, FY2026”, has evaluated
the future growth potential of India sulbactam market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges and
opportunities in India sulbactam market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]